Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Antonio, Texas 78209


Purpose:

This protocol is intended to compare the effects of both a solid (tablet) and liquid oral dosage form of LX4211 in subjects with type 2 diabetes mellitus.


Criteria:

Inclusion Criteria: - Adults aged 18 to 65 years of age - Males and females of non-childbearing potential - Diagnosis of type 2 diabetes mellitus for at least 6 months prior to screening - Fasting plasma glucose ≤240 mg/dL - Body mass index <42 kg/sq m - HbA1c of 7-11% - C-peptide of ≥1.0 ng/mL - Ability to provide written informed consent Exclusion Criteria: - History of type 1 diabetes mellitus, diabetic ketoacidosis, hyperosmolar nonketonic syndrome, incontinence, or nocturia - Current use of any blood glucose-lowering agent other than metformin - Exposure to insulin, thiazide, or loop diuretics within 4 weeks prior to screening - History of HIV, Hepatitis B, or Hepatitis C - Surgery within 6 months of screening - Donation or loss of >400 mL of blood or blood product within 8 weeks prior to start of study - Use of proteins or antibodies within 12 weeks prior to screening. (Flu shots are allowed.) - Exposure to any investigational agent or participation in an investigational trial within 30 days of the start of the study - History of drug or alcohol abuse within 12 months prior to screening.


NCT ID:

NCT01188863


Primary Contact:

Study Director
Joel P. Freiman, MD, MPH
Lexicon Pharmaceuticals, Inc.


Backup Contact:

N/A


Location Contact:

San Antonio, Texas 78209
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.